User: Guest  Login
Title:

Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.

Document type:
Journal Article; Article
Author(s):
Specht, K; Harbeck, N; Smida, J; Annecke, K; Reich, U; Naehrig, J; Langer, R; Mages, J; Busch, R; Kruse, E; Klein-Hitpass, L; Schmitt, M; Kiechle, M; Hoefler, H
Abstract:
Cyclophosphamide, methotrexate and 5-fluorouracile (CMF)-based chemotherapy for adjuvant treatment of breast cancer reduces the risk of relapse. In this exploratory study, we tested the feasibility of identifying molecular markers of recurrence in CMF-treated patients. Using Affymetrix U133A GeneChips, RNA samples from 19 patients with primary breast cancer who had been uniformly treated with adjuvant CMF chemotherapy were analyzed. Two supervised class prediction approaches were used to identif...     »
Journal title abbreviation:
Breast Cancer Res Treat
Year:
2009
Journal volume:
118
Journal issue:
1
Pages contribution:
45-56
Language:
eng
Fulltext / DOI:
doi:10.1007/s10549-008-0207-y
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/18925433
Print-ISSN:
0167-6806
TUM Institution:
Frauenklinik und Poliklinik; Institut für Allgemeine Pathologie und Pathologische Anatomie; Institut für Medizinische Mikrobiologie, Immunologie und Hygiene; Institut für Medizinische Statistik und Epidemiologie
 BibTeX